<DOC>
	<DOCNO>NCT03106441</DOCNO>
	<brief_summary>Oro-tracheal intubation operate room obese patient BMI &gt; 35kg/m2 remains critical event . The aim study determine whether Nasal High Flow Therapy nasal cannula Optiflow® efficient BIPAP preoxygenation orotracheal intubation crash induction obese patient</brief_summary>
	<brief_title>Preoxygenation Optimisation Obese Patients</brief_title>
	<detailed_description>This study design follow : Patients randomize 2 group : - Preoxygenation 4 minute High Flow Nasal Cannula ( 60l/min FiO2 ( fraction inspire oxygen ) = 1 ) orotracheal intubation crash induction . The device maintain place throughout intubation procedure order achieve apnoeic oxygenation . - Or Preoxygenation 4 minute Bi-level Positive Airway Pressure ( BIPAP ) Expiratory Positive Airway Pressure ( EPAP ) + 10 cm H2O Inspiratory Airway Positive Airway Pressure ( IPAP ) + 25 , mean 15cm H2O pressure support . The facial mask remove crash induction enable laryngoscopic vision .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Obese patient BMI &gt; 35kg/m2 Age 18 80 year Requiring crash induction sequence orotracheal intubation . Pulse oxymetry &lt; 90 % ambient air Haemodynamic instability Burned patient Indication intubation vigil spontaneous ventilation Nasopharyngeal obstacle contraindication use Optiflow® device Patients document Cormack IV exposition inclusion Protected adult Pregnancy Lack consent Patient already enrol randomize study look forward improve preoxygenation quality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>